Rocket Pharmaceuticals, Inc. (RCKT)
3.51
+0.09
(+2.63%)
USD |
NASDAQ |
Dec 31, 16:00
3.515
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Market Cap: 379.86M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 52.54B |
| Merck & Co., Inc. | 261.26B |
| Avalo Therapeutics, Inc. | 329.31M |
| Artiva Biotherapeutics, Inc. | 104.52M |
| NovaBay Pharmaceuticals, Inc. | 710.70M |
Market Cap Related Metrics
| Price to Book Value | 1.211 |
| Price | 3.51 |
| Earnings Yield | -64.03% |